AN2 Therapeutics Statistics
Total Valuation
ANTX has a market cap or net worth of $161.26 million. The enterprise value is $81.37 million.
Important Dates
The last earnings date was Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ANTX has 36.00 million shares outstanding. The number of shares has increased by 4.40% in one year.
| Current Share Class | 36.00M |
| Shares Outstanding | 36.00M |
| Shares Change (YoY) | +4.40% |
| Shares Change (QoQ) | +12.20% |
| Owned by Insiders (%) | 6.04% |
| Owned by Institutions (%) | 44.02% |
| Float | 19.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.04 |
| P/TBV Ratio | 2.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.73
| Current Ratio | 15.73 |
| Quick Ratio | 15.33 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -44.56% and return on invested capital (ROIC) is -29.92%.
| Return on Equity (ROE) | -44.56% |
| Return on Assets (ROA) | -27.48% |
| Return on Invested Capital (ROIC) | -29.92% |
| Return on Capital Employed (ROCE) | -45.31% |
| Weighted Average Cost of Capital (WACC) | -1.00% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.65M |
| Employee Count | 21 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +295.73% in the last 52 weeks. The beta is -0.96, so ANTX's price volatility has been lower than the market average.
| Beta (5Y) | -0.96 |
| 52-Week Price Change | +295.73% |
| 50-Day Moving Average | 4.08 |
| 200-Day Moving Average | 2.02 |
| Relative Strength Index (RSI) | 55.10 |
| Average Volume (20 Days) | 237,651 |
Short Selling Information
The latest short interest is 879,488, so 2.44% of the outstanding shares have been sold short.
| Short Interest | 879,488 |
| Short Previous Month | 633,935 |
| Short % of Shares Out | 2.44% |
| Short % of Float | 4.40% |
| Short Ratio (days to cover) | 2.64 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -37.12M |
| Pretax Income | -34.55M |
| Net Income | -34.55M |
| EBITDA | n/a |
| EBIT | -37.12M |
| Earnings Per Share (EPS) | -$1.11 |
Full Income Statement Balance Sheet
The company has $85.29 million in cash and n/a in debt, with a net cash position of $85.29 million or $2.37 per share.
| Cash & Cash Equivalents | 85.29M |
| Total Debt | n/a |
| Net Cash | 85.29M |
| Net Cash Per Share | $2.37 |
| Equity (Book Value) | 81.76M |
| Book Value Per Share | 2.27 |
| Working Capital | 81.93M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -31.28M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ANTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.40% |
| Shareholder Yield | -4.40% |
| Earnings Yield | -20.73% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ANTX is $9.00, which is 100.89% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.00 |
| Price Target Difference | 100.89% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |